ANEUVO’s ExaStim® Earns CE Mark Certification

ANEUVO’s ExaStim® Earns CE Mark Certification

Latest stories

ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®

ANEUVO Launches ASPIRE™ Home Study to Evaluate Home Use of ExaStim®

ANEUVO to Showcase Breakthrough Neuromodulation Device ExaStim® at MEDICA 2024

ANEUVO to Showcase Breakthrough Neuromodulation Device ExaStim® at MEDICA 2024

New Study Investigating the Therapeutic Uses of ExaStim® Among Individuals with Cerebral Palsy

New Study Investigating the Therapeutic Uses of ExaStim® Among Individuals with Cerebral Palsy

New spinal cord stimulation clinical trial gives hope for people living with spinal cord injuries

New spinal cord stimulation clinical trial gives hope for people living with spinal cord injuries

ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal Neuromodulation System to Evaluate its Safety and Effectiveness for Paralysis due to Spinal Cord Injury

ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal Neuromodulation System to Evaluate its Safety and Effectiveness for Paralysis due to Spinal Cord Injury

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About Aneuvo

About ANEUVO 

ANEUVO is developing revolutionary bioelectronic medicine to help restore functional independence, improve quality of life, and create a healthier and more equitable world for people living with chronic diseases and conditions. Leveraging the company’s advanced biotechnology platform and deep expertise, ANEUVO is tackling critical healthcare challenges to deliver meaningful solutions to underserved patients in need. For more information, visit www.aneuvo.com.

Contact

10940 Wilshire Blvd Suite 2030 Los Angeles, CA 90024